Machine‐learning based subgroups of <scp>AL</scp> amyloidosis and cumulative incidence of mortality and end stage kidney disease
Shankara Anand(Broad Institute), Ashish Verma, Lisa Mendelson(Boston University), Tracy Joshi(Boston University), Vaishali Sanchorawala(Boston Medical Center), Andrew Staron(Boston University), Natasha Burke(Boston University)
Cited by 7
Related Papers
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
|American Journal of Hematology|2005|1.4k
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study
|Annals of Internal Medicine|2004|615
Systemic immunoglobulin light chain amyloidosis
|Nature Reviews Disease Primers|2018|550
A Quantitative Proteome Map of the Human Body
|Cell|2020|485